Lidocaine Hydrochloride Injection, Solution
Product Images NDC 71872-7160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 71872-7160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7160-1 Pdp (71872 7160 1)

71872-7160-1 Pdp (71872 7160 1)
This is a single-dose syringe of 1% Lidocaine HCI Injection, USP with a strength of 50mg/5mL (10mg/mL) used for intravenous Ventricular Arrhythmias treatment. It is manufactured by Hospira, Inc. in Lake Forest, IL, USA, and distributed by Medical Purchasing Solutions in Scottsdale, AZ, USA. The medication and fluid path are sterile and non-pyrogenic. The pH of this solution ranges between 5.0 to 7.0 and may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. Only the usual dosage as mentioned in the insert should be used, and the unused portion should be discarded. The package contains 1 Box Lot with Lot# XXXX and an expiration date of XXX. It should be stored at a temperature of 20°C to 25°C (68°F to 77°F), and variations are permitted between 15°C and 30°C (59°F and 86°F).*
FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine Hydrochloride 01)

FDA Label Image

Logo (Lidocaine Hydrochloride 02)

FDA Label Image

Principal Display Panel (10 mg/mL Syringe Label)

Principal Display Panel (10 mg/mL Syringe Label)
This is a description of a 1% Lidocaine HCI Injection, usp. It is available in a 5 mL single-dose syringe and contains 50 mg of lidocaine HCI per 5 mL (10 mg/mL). The syringe is distributed by Hospira, and is for intravenous use to treat ventricular arrhythmias. The lot number and expiration date are also provided.*
FDA Label Image

Principal Display Panel (10 mg/mL Syringe Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.